Underdosing of drugs affecting uric acid metabolism, sequela

This code signifies a long-term complication or residual effect resulting from the patient not receiving enough of a medication intended to regulate uric acid levels. This underdosing could lead to persistent or recurrent conditions related to hyperuricemia, such as chronic gouty arthritis or kidney stones. It indicates that the initial underdosing event is no longer the acute issue, but its lasting impact is being addressed.

Apply this code when documenting a patient presenting with a chronic condition or lasting symptom that is directly attributable to a past instance of insufficient dosing of uric acid-modifying drugs. This is appropriate for follow-up encounters where the sequelae of underdosing, rather than the acute underdosing event itself, are being managed. Examples include managing chronic tophaceous gout in a patient with a history of poor adherence to allopurinol.

• Always use this code as a secondary diagnosis, following the code for the specific condition (e.g., gout, nephrolithiasis) that is the sequela.
• Ensure documentation clearly links the current condition to a past underdosing event of uric acid-affecting medications.
• Distinguish from acute underdosing (initial encounter) or poisoning (adverse effect of correct dose).